Min Zheng
- Hepatology top 1%
- Hepatitis C virus research 11
- Liver physiology and pathology 10
- Cancer Research top 1%
- MicroRNA in disease regulation 15
- Clinical Biochemistry top 0.5%
- Geriatrics and Gerontology top 1%
- Immunology top 1%
-
- Liver Disease Diagnosis and Treatment 32
- Hepatitis B Virus Studies 20
-
- Ubiquitin and proteasome pathways 12
- Extracellular vesicles in disease 11
-
- Cancer-related Molecular Pathways 10
- Co-authors
- Yanning LiuYu ShiZhi ChenYing YangQiao YangJiliang HeHangdi XuShuping Li
- Journals
- Journal of the American Chemical Society (1 paper)Nucleic Acids Research (1 paper)Nature Communications (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Min Zheng
235 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Hepatology 898
- Cancer Research 1.7k
- Clinical Biochemistry 619
- Geriatrics and Gerontology 327
- Immunology 1.6k
Countries citing papers authored by Min Zheng
This map shows the geographic impact of Min Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Zheng more than expected).
Fields of papers citing papers by Min Zheng
This network shows the impact of papers produced by Min Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Zheng. The network helps show where Min Zheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Zheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 54 | |
| 11 | 2022 | 29 | |
| 12 | 2021 | 22 | |
| 13 | 2020 | 12 | |
| 14 | 2019 | 27 | |
| 15 | Evaluation on elasticity of carotid artery with QAS and X-strain technique in patients with systemic lupus erythematosus | 2014 | 1 |
| 16 | An Experimental Study of Analgesic Effects of Sambucus Decoction on Mice | 2012 | 1 |
| 17 | Fatty acid composition of human breast milk in Shanghai and Chongqing of China | 2011 | 2 |
| 18 | 2010 | 81 | |
| 19 | 2009 | 83 | |
| 20 | DNA Microarray Analysis of Mouse Contralateral Eye Following HSV-1 Anterior Chamber Inoculation | 2002 | 1 |
About Min Zheng
Min Zheng is a scholar working on Hepatology, Cancer Research and Epidemiology, having authored 247 papers that have together received 9.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (32 papers), Hepatitis B Virus Studies (20 papers), MicroRNA in disease regulation (15 papers), Ubiquitin and proteasome pathways (12 papers), Hepatitis C virus research (11 papers), Extracellular vesicles in disease (11 papers), Liver physiology and pathology (10 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Hepatology (898 citations), Cancer Research (1.7k citations) and Clinical Biochemistry (619 citations). Min Zheng has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Yanning Liu, Yu Shi, Zhi Chen, Ying Yang, Qiao Yang, Jiliang He, Hangdi Xu, Shuping Li, Guangzhong Song and Feng Chen. Their work appears in journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.